From approval to access: Europe’s next health imperative
Europe’s health ambition is returning to the political agenda. With a focus on clinical trials, biotechnology and cardiovascular health, the Health Package signals Brussels’ intent to prioritize innovation, research and prevention as pillars of Europe’s competitiveness and resilience. But for many patients, one reality remains unchanged: access to innovative medicines remains too slow. Today, European patients are waiting longer than ever … Read more